APA (7th ed.) Citation

Fang, J., Xu, Y., Lin, C., Yang, J., Zhai, D., Zhuang, Q., . . . Zhang, L. (2024). Increasing serum miR-223-3p indicates the onset, severe development, and adverse prognosis of bronchiectasis. BMC Pulmonary Medicine, 24(1), . https://doi.org/10.1186/s12890-024-03170-y

Chicago Style (17th ed.) Citation

Fang, Jia, Yao Xu, Chenghui Lin, Jiewen Yang, Dongxu Zhai, Qingyuan Zhuang, Wangli Qiu, Yun Wang, and Longjuan Zhang. "Increasing Serum MiR-223-3p Indicates the Onset, Severe Development, and Adverse Prognosis of Bronchiectasis." BMC Pulmonary Medicine 24, no. 1 (2024). https://doi.org/10.1186/s12890-024-03170-y.

MLA (9th ed.) Citation

Fang, Jia, et al. "Increasing Serum MiR-223-3p Indicates the Onset, Severe Development, and Adverse Prognosis of Bronchiectasis." BMC Pulmonary Medicine, vol. 24, no. 1, 2024, https://doi.org/10.1186/s12890-024-03170-y.